Skip to content

Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

A Prospective Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04782674
Enrollment
40
Registered
2021-03-04
Start date
2021-03-15
Completion date
2022-04-30
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EBV Infection

Brief summary

This study is a single-center, prospective, observational clinical study to evaluate the Application of saliva EBV-DNA Detection in EBV Infection Related Diseases

Interventions

DIAGNOSTIC_TESTSaliva Testing

Saliva EBV-DNA Detection comparing with PBMC and plasma EBV-DNA

Sponsors

Beijing Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. According to the HLH-04 diagnostic criteria, it meets the HLH diagnostic criteria. EBV infection occurs in cells with EBV-DNA copy number significantly increased in peripheral blood or tissue, or where EBV coding small RNA(EBER) is detected in tissue or peripheral blood. Or Straus' 1988 diagnostic criteria for CAEBV. 2. Informed consent

Exclusion criteria

1. Patients who cannot cooperate with saliva collection 2. Patients who are unwilling to cooperate with the project research according to the project research plan.

Design outcomes

Primary

MeasureTime frameDescription
DiagnosisbaselineThe sensitivity and specificity of saliva EBV-DNA detection level as a diagnosis for EBV infection-related diseases, and whether it can replace peripheral blood EBV-DNA monitoring
Monitoring2 to 12 weeks after treatmentThe sensitivity and specificity of saliva EBV-DNA detection level as a monitoring method for EBV infection-related diseases, and whether it can replace peripheral blood EBV-DNA monitoring

Countries

China

Contacts

Primary ContactZhao Wang, Dr
wangzhao@ccmue.du.cn+8618810253070

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026